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Abstract
Background: Animal models suggest that neuroprotective 
effects of therapeutic hypothermia (TH) after perinatal as-
phyxia are reduced in infants with early-onset sepsis. Objec-
tives: To assess the outcome of infants with perinatal as-
phyxia, neonatal encephalopathy, and TH in the presence of 
early-onset sepsis. Methods: In a retrospective cohort of 
1,084 infants with perinatal asphyxia and TH, the outcome of 
42 infants (gestational age 36.1–42.6 weeks and birth weight 
2,280–5,240 g) with proven sepsis (n = 14) and probable sep-
sis (n = 28) was analyzed. Death, cerebral palsy, or a delayed 
development at 2 years was considered an adverse out-
come. Results: Sepsis was caused mostly by group B strep-
tococci (n = 17), other Gram-positive bacteria (n = 5), and 
Candida albicans (n = 1). Of the 42 infants, 9 (21.4%) died, and 
5 (11.9%) showed impairments on follow-up. The outcome 
is comparable to the previously reported outcome of infants 
with TH without early-onset sepsis. Conclusion: A good out-
come was reported in the majority of infants with perinatal 
asphyxia, TH, and early-onset sepsis. Cooling should not be 
withheld from these infants. © 2018 The Author(s) 
Published by S. Karger AG, Basel
This article is licensed under the Creative Commons Attribution-
NonCommercial-NoDerivatives 4.0 International License (CC BY-
NC-ND) (http://www.karger.com/Services/OpenAccessLicense). 
Usage and distribution for commercial purposes as well as any dis-
tribution of modified material requires written permission.
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Introduction
Neonatal encephalopathy (NE) following perinatal as-
phyxia in term neonates is still a common and serious 
condition. The prevalence of NE after perinatal asphyxia 
is approximately 1–6 per 1,000 full-term live births [1, 2]. 
It is well known that infants with moderate-to-severe NE 
carry a high risk of adverse outcome, such as cerebral pal-
sy (CP), neurodevelopmental impairment, or mortality, 
even after therapeutic hypothermia (TH) [1, 3, 4]. In ad-
dition, early-onset sepsis which is mostly caused by group 
B streptococcus (GBS) or Gram-negative organisms, such 
as Escherichia coli, carries a high risk of an adverse out-
come [5]. The outcome of infants with perinatal asphyxia, 
early-onset sepsis, and TH has not been reported in much 
detail. It has been suggested that encephalopathic new-
borns with early-onset sepsis may have a worse outcome 
compared to nonseptic neonates [6]. Studies in adults 
with sepsis did not show benefits of hypothermia [7]. In 
addition, in the study by Geurts et al. [8] an increased 
risk for pneumonia and sepsis was observed, although 
the overall infection risk was not significantly higher. At 
present, little is known about the interplay of hypother-
mia and sepsis. Several animal models have examined the 
neuroprotective effect of TH in the presence of bacterial 
infections and results are inconclusive [9–12].
In the present study, the outcome of infants with peri-
natal asphyxia, NE treated with hypothermia, and early-
onset sepsis was assessed.
Subjects and Methods
Infants with a gestational age between 36 + 0 and 42 + 0 weeks 
with perinatal asphyxia, NE, and TH admitted to one of the level 
III participating Neonatal Intensive Care Units (NICU) in the 
Netherlands or Flanders, Belgium, between January 2008 and De-
cember 2016 were included. During this period, 1,084 infants were 
treated with TH in the participating hospitals. Retrospectively, 
data were collected from the medical files. Growth percentiles were 
calculated according to the Netherlands Perinatal Registry Birth 
Weight centiles (www.perined.nl) [13].
Infants with positive blood cultures within 48 h after birth and 
clinical signs of sepsis were considered to have a proven sepsis. In-
fants with clinical signs of early-onset sepsis and an elevated CRP 
(≥50 mg/L) or positive surface cultures, but no positive blood cul-
ture, were considered to have a probable sepsis. All infants were 
treated with antibiotics for at least 7 days, and all had signs of 
multi-organ failure. Most infants were too ill to undergo lumbar 
punctures.
The severity of encephalopathy was graded according to Sar-
nat. TH was used as described previously [3]. Although 3 infants 
appeared to have a mild encephalopathy, aEEG showed a sup-
pressed background pattern and TH was applied. In 3 infants with 
a good aEEG background pattern on admission, TH was started 
because of a high Thompson score.
In all infants, aEEG was used routinely, and patterns were ana-
lyzed as described previously [14]. Clinical and/or aEEG-detected 
seizures were treated according to the Dutch/Flemish neonatal sei-
zure protocol which includes phenobarbital with midazolam and/
or lidocaine as add-on therapy [15]. Brain imaging (cranial ultra-
sound and MRI) was collected from the files. MRI abnormalities 
were reported as watershed lesions, lesions in the basal ganglia and 
thalamus (BGT), or near total injury [16].
Outcome
After discharge, follow-up assessments were performed in the 
participating hospitals at regular intervals up to at least 18 months 
in the routine follow-up program. Death, CP, neurodevelopmental 
impairment of > 3 months, a Griffiths’ developmental quotient 
< 88 (–1 standard deviation, SD), or a score on the Bayley Scales of 
Infant and Toddler Development-III < 85 (–1 SD) were all consid-
ered an adverse outcome. In addition, infants (n = 4) with a normal 
MRI at birth and having no neurological abnormalities at the age 
of 6 months, and 2 additional infants with a normal MRI and no 
follow-up data were categorized in the group with no adverse out-
come.
Statistical Analysis
Mortality and adverse neurodevelopmental outcome data were 
compared to the data reported previously in our units [3] and a 
Cochrane review [4], using χ2 tests, Fisher tests, or analysis of vari-
ance (ANOVA) where appropriate. Data were expressed as mean 
± SD, median with interquartile range (IQR), or in percentages. 
With the number of 42 patients, it would be possible to compare 
neuroprotective effects of hypothermia in septic patients (both 
proven and probable sepsis combined) with all hypothermia pa-
tients presented in the studies mentioned above [3, 4] with an al-
pha of 0.05 and a power of 0.80. This retrospective study was ap-
proved by the local ethics committee, and the requirement to ob-
tain informed consent for this study with anonymous data analysis 
was waived according to national regulations.
Results
Between January 2008 and December 2017, 42 infants 
with perinatal asphyxia and TH showed early-onset sep-
sis. Of these 42 infants, 14 infants had proven sepsis and 
28 probable sepsis. Clinical data of our patients are pre-
sented in Table 1. Clinical data were not significantly dif-
ferent between the proven and probable sepsis groups. 
Gestational age and birth weight were lower in the neo-
nates who died (n = 9) compared to the ones who survived 
(n = 33); however, the 5th and the 10th percentile birth 
weights were similar. Infants who died had a higher 
Thompson score and a more severe encephalopathy. 
Clinical data of the patients with sepsis, such as gesta-
tional age, birth weight, and severity of encephalopathy 
were comparable to those reported in other studies of 
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TH in the Cochrane review by Jacobs et al. [4] and in 
Groenendaal et al. [3].
Microbiology
The children with proven sepsis showed a positive 
blood culture with Gram-positive bacteria, which includ-
ed GBS (n = 10), Actinomyces (n = 1), coagulase-negative 
staphylococci (n = 1), Streptococcus viridans (n = 1), and 
Streptococcus milleri (n = 1, Table 2). The infant with S. 
viridans-proven sepsis died. The infants with proven sep-
sis who survived developed no neurological impairments. 
Some neonates in the probable sepsis group had no sur-
face cultures taken (n = 19). These infants were diagnosed 
with probable sepsis based on their high CRP values and 
clinical symptoms, leaving 9 neonates with a positive sur-
face with Gram-positive bacteria (GBS, n = 7, and Entero-
coccus hirae, n = 1) or fungus (Candida, n = 1). There was 
no significant difference in adverse outcome, considering 
the type of organism found in blood or surface culture 
(Table 2).
Table 1. Clinical data
Characteristics All early-onset
septic infants
(n = 42)
Probable
sepsis
(n = 28)
Proven
sepsis
(n = 14)
p
value*
Survived
(n = 33)
Died
(n = 9)
p
value+
Gestational age, weeks 40.1±1.55 40.0±1.49 40.2±1.72 0.75 40.3±1.45 39.1±1.65 0.04
Female 21 (50.0) 14 (50.0) 7 (50.0) 1.00 16 (48.5) 5 (55.6) 0.71
Birthweight 3,659±662 3,660±726 3,658±534 0.99 3,814±619 3,094±502 0.003
P5 for SGA 4 (9.5) 3 (10.7) 1 (7.1) 1.00 2 (6.1) 2 (22.2) 0.20
P10 for SGA 6 (14.3) 4 (14.3) 2 (14.3) 1.00 3 (9.1) 3 (33.3) 0.10
Mode of birth (n = 39a) 0.56 0.42
Section 16 (41.0) 10 (37.0) 6 (50.0) 12 (40.0) 4 (44.4)
SVD 18 (46.2) 14 (51.9) 4 (33.3) 13 (43.3) 5 (55.6)
Vacuum extraction 5 (12.8) 3 (11.1) 2 (16.7) 5 (16.7) 0 (0.0)
Meconium (n = 34a) 19 (55.9) 11 (50.0) 8 (66.7) 0.35 14 (51.9) 5 (71.4) 0.35
Grade of encephalopathy on 
admission (n = 21b) 0.75 <0.0001
Mild 3 (14.3) 2 (16.7) 1 (11.1) 3 (18.8) 0 (0.0)
Moderate 12 (57.1) 6 (50.0) 6 (66.7) 12 (75.0) 0 (0.0)
Severe 6 (28.6) 4 (33.3) 2 (22.2) 1 (6.3) 5 (100)
Apgar score (n = 41a)
1 min 1 [2] 1 [2] 1.5 [2] 0.57 1 [2] 0 [2] 0.14
5 min 3 [3] 3 [3] 3.5 [3] 0.39 3.5 [2] 2 [5] 0.4
pHc (n = 34a) 6.98±0.20 7.03±0.20 6.91±0.17 0.07 6.98±0.21 7.0±0.13 0.93
Thompson score (n = 35a) 10 [3] 10 [3] 10 [2] 0.89 10 [3] 13 [3] 0.02
Antiepileptic drugs ≥1 (n = 37a) 26 (70.3) 15 (60.0) 11 (91.7) 0.06 20 (71.4) 6 (66.7) 0.79
Highest CRP during hypothermia 
(n = 39a) 106±72.5 94±54.5 135±103 0.11 103±69.0 116±89.5 0.65
aEEG on admission (n = 33a) 0.58 0.06
CNV 3 (9.1) 3 (13.6) 0 (0.0) 3 (12.0) 0 (0.0)
DNV 6 (18.2) 4 (18.2) 2 (18.2) 6 (24.0) 0 (0.0)
BS 13 (39.4) 7 (31.8) 6 (54.5) 11 (44.0) 2 (25.0)
LV 5 (15.2) 4 (18.2) 1 (9.1) 2 (8.0) 3 (37.5)
FT 6 (18.2) 4 (18.2) 2 (18.2) 3 (12.0) 3 (37.5)
Mortality 9 (21.4) 6 (21.4) 3 (21.4) 1.00 – – –
Values are expressed as means ± SD, numbers with percentage in parentheses, or medians with IQR in square brackets. Bold values 
are p < 0.05. SGA, small for gestational age; P5, 5th percentile; P10, 10th percentile; SVD, spontaneous vaginal delivery; aEEG, amplitude-
integrated electroencephalography; CNV, continuous normal voltage; DNV, discontinuous normal voltage; BS, burst suppression; LV, 
low voltage; FT, flat trace. 
a Percentages are based on data that were available from the number of infants in the institutions. It means that some data were 
missing. b Data were missing for 21 infants. c The umbilical arterial pH was not reported in 8 infants. * p values were calculated between 
probable and proven sepsis. + p values were calculated between infants who survived and those who died.
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Outcome
Imaging
Findings of cranial MRI examinations at follow-up are 
presented in Table 3. The MRI showed no abnormalities 
in 51.4% of the infants with sepsis. Infants who died had 
more severe MRI abnormalities (p < 0.0001). Four infants 
(11.4%) had a near total pattern on the MRI. Of the 4 in-
fants with a near total pattern, 3 died and 1 survived but 
developed neurological disabilities. The aEEG of these 4 
neonates showed a flat trace or continuous low voltage 
and 2 had a Thompson score of > 11. Furthermore, 6 neo-
nates (17.1%) had BGT involvement on the MRI, and 7 
neonates (20%) had a watershed-type injury. One infant 
with a BGT pattern died and 2 developed neurological 
disabilities. Finally, there was no difference in MRI results 
between proven and probable sepsis (p = 0.992).
Mortality
The overall mortality among septic infants with TH 
after asphyxia was 21.4%. Two infants died shortly after 
admission due to severe sepsis, 7 others died after redirec-
tion of care following severe brain injury which was dem-
onstrated using MRI. Postmortem examination was per-
formed in 2 infants, confirming the multi-organ involve-
ment and MRI findings. No significant difference was 
found in mortality between the proven and probable sep-
sis groups. The mortality in the present study (21.4%) was 
comparable to the previous study (31.8%) and the Co-
chrane review (26.8%; Table 4).
Follow-Up
Outcome data on Neurodevelopmental disabilities 
or CP are presented in Table 4. Of the 42 neonates, 33 
(78.6%) infants survived. Among the survivors, 5 (15.1%) 
had neurodevelopmental impairment including CP. 
Three infants were too young to be formally tested or had 
no follow-up. The remaining 25 infants with perinatal as-
phyxia and early-onset sepsis were normal (59.5%). Hy-
pothermia-treated survivors with sepsis had no differ-
ence in the incidence of adverse outcome compared to the 
previous TH studies.
Discussion
In the present study, the outcome of septic neonates 
who underwent TH was reported. During the study pe-
riod, 42 of the 1,084 infants (3.9%) had proven or prob-
able early-onset sepsis. Whereas one-third had an adverse 
outcome, more than 60% was normal at 18 months or 
later. An additional 2 younger infants were too young to 
be formally tested but were normal at this younger age. 
These outcomes are comparable to the data reported in 
large RCTs and the results of previously reported patients 
in the Netherlands and Flanders, Belgium, without sepsis 
[4, 17–20].
Table 2. Bacteria cultured in infants with a proven or probable sep-
sis
Proven
sepsis
(n = 14)
Probable
sepsis
(n = 28)
Adverse 
outcome 
Surface or blood culturea
GBS 10 (71.4) 7 (77.8) 6
CNS 1 (7.1) – 0
Actinomyces oris 1 (7.1) – 0
Streptococcus milleri 1 (7.1) – 0
Streptococcus viridansb 1 (7.1) – 1
Enterococcus hirae – 1 (11.1) 0
Candida – 1 (11.1) 0
Unknownc – 19 (45.2) 7
Values are expressed as numbers with percentages in 
parentheses. GBS, group B streptococcus; CNS, coagulase-negative 
staphylococcus.
a Surface culture was taken from the ear and/or umbilicus, with 
missing data for 19 infants. b This infant with S. viridans sepsis 
developed a coinfection with CNS at birth. c These infants were 
included in the probable sepsis group due to clinical signs of sepsis 
and a CRP >50 mg/L.
Table 3. MRI data and survival
Characteristics Probable
sepsis
(n = 28)
Proven 
sepsis
(n = 14)
Survived
(n = 33)
Died
(n = 9)
MRI (n = 35)a
Normal 13 (46.4) 5 (35.7) 18 (54.5) 0 (0.0)
WS 5 (17.8) 2 (14.3) 7 (21.2) 0 (0.0)
BGT 4 (14.3) 2 (14.3) 5 (15.2) 1 (11.1)
NT 3 (10.7) 1 (7.1) 1 (3.0) 3 (33.3)
Not performed 3 (10.7) 4 (28.6) 2 (6.1) 5 (55.6)
Values are expressed as numbers with percentages in 
parentheses. MRI, magnetic resonance imaging; WS, watershed 
pattern of injury; BGT, basal ganglia and thalamus pattern of 
injury; NT, “near total” pattern of injury. 
a MRI was not performed in 7 infants, of whom 5 died.
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Infections with GBS are still an important cause of se-
rious morbidity in neonates [21]. In the present study, the 
outcome of infants with infections caused by GBS was not 
different from infections caused by other organisms. In-
fections with Gram-negative organisms were not seen in 
the present study. In the Netherlands, early-onset sepsis 
with Gram-negative organisms in full-term infants is very 
rare (data from the Netherlands Perinatal Registry, www.
perined.nl).
TH has a neuroprotective effect by influencing differ-
ent pathways including metabolism, cerebral blood 
flow, the release of excitatory amino acids, and apopto-
sis. Furthermore, TH has an antioxidant effect, the abil-
ity to block the proinflammatory cascade and reduce 
ATP loss [6, 22]. During sepsis, metabolic demands in 
different organs are high due to the inflammation re-
sponse, which may increase neuronal apoptosis and 
subsequent neurological damage. Based on this theory, 
TH could also be effective in infants with early-onset 
sepsis. In contrast, hypothermia may suppress the po-
tentially protective inflammatory cascade and may re-
sult in functional immune compromise, leading to an 
adverse outcome in infants with sepsis [23]. Animal ex-
periments have described conflicting results in models 
of perinatal asphyxia and infections. Neuroprotective 
effects have been described in neonatal models of Gram-
positive sepsis and TH [11], whereas a lack of effects has 
been detected in neonatal models of Gram-negative sep-
sis and TH [9, 10]. In contrast, prolonged survival in 
Gram-negative sepsis was documented in adult models 
of Gram-negative and Gram-positive sepsis and TH [12, 
24].
The large trials of TH in perinatal asphyxia and NE 
have not described the effects of TH in infants with early-
onset sepsis in much detail. TH may increase the risk of 
infections [23]. A meta-analysis in adults strongly sug-
gested an association between TH and the risk of pneu-
monia and sepsis [8]. In main randomized trails, solely 
5–11.3% of infants developed sepsis [17, 18, 20, 25]. How-
ever, early-onset sepsis has not been defined in much de-
tail in most trials, and in many studies no difference was 
reported between early and late-onset sepsis. In the pres-
ent study, 14 of the infants developed late-onset sepsis 
which is higher number compared to the study of Jacobs 
et al. [25].
Our study has several limitations. First, it had a retro-
spective design, and some clinical data were not reported 
in much detail. Furthermore, some units did not perform 
routine surface cultures, thereby limiting the detection of 
the causative organism in infants with clinical sepsis. The 
effect of TH on CRP levels is controversial [26, 27]. Nev-
ertheless, by using very high cutoff values for CRP (> 50 
mg/L), twice the upper level as those mentioned by oth-
ers [28, 29], and a clinical picture of early-onset sepsis, 
we considered the risk of false positives to be low. Sec-
ond, follow-up was not performed uniformly, which may 
have led to somewhat diverse outcome data. By using 
cutoff values of the separate tests, we were able to iden-
tify infants with an adverse outcome. Third, the numbers 
of sepsis cases were too small to provide detailed infor-
mation on the outcome of Gram-positive versus Gram-
negative neonatal sepsis, but the sample size was large 
enough to demonstrate that neuroprotection by TH was 
retained in infants with perinatal asphyxia and early-on-
set sepsis. Furthermore, no lumbar puncture was per-
formed in most infants because of the severity of illness, 
and the presence of accompanying meningitis is un-
known.
Table 4. Outcome of septic neonates with TH after asphyxia compared to previous studies [3, 4]
Outcome Early-onset sepsis
(n = 42)
Groenendaal et al. [3]
(n = 308)
p value* Cochrane review [4] 
(n = 678)
p value+
Normal outcome 26 (61.9) 168 (54.5) 0.37 366 (54.0) 0.32
Neurodevelopmental
impairment or CP 5 (11.9) 42 (13.6) 0.76 130 (19.2) 0.24
Mortality 9 (21.4) 98 (31.8) 0.17 182 (26.8) 0.44
Adverse outcome 14 (33.3) 140 (45.5) 0.14 312 (46.0) 0.11
Too young to be tested 2 (4.8) – – – –
Values are expressed as numbers with percentages in parentheses. * Significant difference was calculated between the early-onset 
sepsis group and Groenendaal et al. [3]. + Significant difference was calculated between the early-onset sepsis group and the Cochrane 
review [4].
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Conclusion
A good outcome was reported in more than 60% of 
infants with perinatal asphyxia, sepsis, and therapeutic 
hypothermia. Therapeutic hypothermia should not be 
withheld from infants with perinatal asphyxia, neonatal 
encephalopathy, and early-onset sepsis.
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